Journal of Neurology

, Volume 261, Issue 1, pp 66–72

The effect of an APOE polymorphism on cognitive function depends on age

  • Min-Ho Shin
  • Sun-Seog Kweon
  • Jin-Su Choi
  • Young-Hoon Lee
  • Hae-Sung Nam
  • Kyeong-Soo Park
  • Hee N. Kim
  • Hye-Rim Song
  • Byeong C. Kim
  • Seong-Min Choi
  • Sun-Young Oh
  • Seul-Ki Jeong
Original Communication

Abstract

It remains controversial whether APOE E4 polymorphism is related to cognitive function in general population. We aimed to evaluate an association between the APOE E4 genotype and cognitive function, and whether this association may differ by age. Cognitive function was assessed using the Korean version of modified Mini-Mental State Examination (K-mMMSE) in 10,371 Koreans aged 45–74 years in Namwon City. According to the APOE E4 status, all participants were classified as non-carriers, heterozygotes, or homozygotes. Multiple linear and logistic regression models were used to evaluate the association between APOE genotypes and cognition. The frequency of APOE genotypes in the study population was 0.4, 10.1, 1.1, 72.9, 14.7 and 0.8 % for E2E2, E2E3, E2E4, E3E3, E3E4, and E4E4, respectively. Compared to the APOE E4 non-carriers, the heterozygotes and homozygotes showed 1.3 and 7.3 % lower K-mMMSE scores at 65–74 years and 0.8 and 4.6 % higher scores at 45–55 years, respectively. Educational attainment modified the effect of APOE E4 on cognitive function in the 45–54 age group (p for interaction =0.003), showing that the E4 carriers with no-formal education showed significantly higher cognitive function than those with formal education. The present study demonstrates that the effect of APOE E4 on cognitive function depends on age and education.

Keywords

Age Apolipoprotein E Cognition Genetic polymorphism K-mMMSE 

References

  1. 1.
    Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Gen 39:17–23CrossRefGoogle Scholar
  2. 2.
    Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43:1467–1472CrossRefPubMedGoogle Scholar
  3. 3.
    Liu F, Pardo LM, Schuur M, Sanchez-Juan P, Isaacs A, Sleegers K, de Koning I, Zorkoltseva IV, Axenovich TI, Witteman JC, Janssens AC, van Swieten JC, Aulchenko YS, Oostra BA, van Duijn CM (2010) The apolipoprotein E gene and its age-specific effects on cognitive function. Neurobiol Aging 31:1831–1833CrossRefPubMedGoogle Scholar
  4. 4.
    Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255–263PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Izaks GJ, Gansevoort RT, van der Knaap AM, Navis G, Dullaart RP, Slaets JP (2011) The association of APOE genotype with cognitive function in persons aged 35 years or older. PLoS One 6:e27415PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Kweon SS, Shin MH, Jeong SK, Nam HS, Lee YH, Park KS, Ryu SY, Choi SW, Kim BH, Rhee JA, Zheng W, Choi JS (2013) Cohort profile: the Namwon study and the Dong-gu study. Int J Epidemiol. doi:10.1093/ije/dys244 PubMedGoogle Scholar
  7. 7.
    Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548PubMedGoogle Scholar
  8. 8.
    Shin MH, Kim HN, Cui LH, Kweon SS, Park KS, Heo H, Nam HS, Jeong SK, Chung EK, Choi JS (2005) The effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci 20:361–366PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Jeong SK, Cho KH, Kim JM (2004) The usefulness of the Korean version of modified mini-mental state examination (K-mMMSE) for dementia screening in community dwelling elderly people. BMC Pub Heal 4:31CrossRefGoogle Scholar
  10. 10.
    Jeong SK, Lim ES, Nam HS, Kweon SS, Park KS, Shin MH, Choi JS (2007) Population-based norms for the Korean mini-mental state examination and Korean version of modified mini-mental state examination. J Korean Neurol Assoc 25:1–9Google Scholar
  11. 11.
    Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342:697–699CrossRefPubMedGoogle Scholar
  12. 12.
    Small BJ, Rosnick CB, Fratiglioni L, Backman L (2004) Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 19:592–600CrossRefPubMedGoogle Scholar
  13. 13.
    Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 55:1777–1785CrossRefPubMedGoogle Scholar
  14. 14.
    Seeman TE, Huang MH, Bretsky P, Crimmins E, Launer L, Guralnik JM (2005) Education and APOE-e4 in longitudinal cognitive decline: Macarthur studies of successful Aging. J Gerontol B Psychol Sci Soc Sci 60:P74–P83CrossRefPubMedGoogle Scholar
  15. 15.
    Ruiz A, Hernandez I, Ronsende-Roca M, Gonzalez-Perez A, Rodriguez-Noriega E, Ramirez-Lorca R, Mauleon A, Moreno-Rey C, Boswell L, Tune L, Valero S, Alegret M, Gayan J, Becker JT, Real LM, Tarraga L, Ballard C, Terrin M, Sherman S, Payami H, Lopez OL, Mintzer JE, Boada M (2013) Exploratory analysis of seven Alzheimer’s disease genes: disease progression. Neurobiol Aging 34(1310):e1311–e1317Google Scholar
  16. 16.
    Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, Ihara Y (2000) Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol 157:2093–2099PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030–1035PubMedCentralPubMedGoogle Scholar
  18. 18.
    Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM (2003) Decreased beta-amyloid1–42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 289:2094–2103CrossRefPubMedGoogle Scholar
  19. 19.
    Koffie RM, Hashimoto T, Tai H-C, Kay KR, Serrano-Pozo A, Joyner D, Hou S, Kopeikina KJ, Frosch MP, Lee VM, Holtzman DM, Hyman BT, Spires-Jones TL (2012) Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β. Brain 135:2155–2168PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Canuet L, Tellado I, Couceiro V, Fraile C, Fernandez-Novoa L, Ishii R, Takeda M, Cacabelos R (2012) Resting-state network disruption and APOE genotype in Alzheimer’s disease: a lagged functional connectivity study. PLoS One 7:e46289PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at three levels of genetic risk for Alzheimer’s disease. Proc Natl Acad Sci USA 106:6820–6825PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Rusted JM, Evans SL, King SL, Dowell N, Tabet N, Tofts PS (2013) APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. Neuroimage 65:364–373CrossRefPubMedGoogle Scholar
  23. 23.
    Han SD, Drake AI, Cessante LM, Jak AJ, Houston WS, Delis DC, Filoteo JV, Bondi MW (2007) Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? J Neurol Neurosurg Psychiatry 78:1103–1108PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, Henke K (2007) Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 17:1934–1947CrossRefPubMedGoogle Scholar
  25. 25.
    Yu YW, Lin CH, Chen SP, Hong CJ, Tsai SJ (2000) Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. Neurosci Lett 294:179–181CrossRefPubMedGoogle Scholar
  26. 26.
    Han SD, Bondi MW (2008) Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement 4:251–254CrossRefPubMedGoogle Scholar
  27. 27.
    Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer’s disease. Nature 461:916–922PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Bunce D, Anstey KJ, Burns R, Christensen H, Easteal S (2011) Does possession of apolipoprotein E epsilon4 benefit cognitive function in healthy young adults? Neuropsychologia 49:1693–1697CrossRefPubMedGoogle Scholar
  29. 29.
    Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease Meta analysis consortium. JAMA 278:1349–1356CrossRefPubMedGoogle Scholar
  30. 30.
    Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487–495CrossRefPubMedGoogle Scholar
  31. 31.
    Albin RL (1993) Antagonistic pleiotropy, mutation accumulation, and human genetic disease. Genetica 91:279–286CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Min-Ho Shin
    • 1
  • Sun-Seog Kweon
    • 1
    • 2
  • Jin-Su Choi
    • 1
  • Young-Hoon Lee
    • 3
  • Hae-Sung Nam
    • 4
  • Kyeong-Soo Park
    • 5
  • Hee N. Kim
    • 6
  • Hye-Rim Song
    • 1
  • Byeong C. Kim
    • 7
  • Seong-Min Choi
    • 7
  • Sun-Young Oh
    • 8
  • Seul-Ki Jeong
    • 8
  1. 1.Department of Preventive MedicineChonnam National University Medical SchoolGwangjuRepublic of Korea
  2. 2.Jeonnam Regional Cancer Center, Hwasun HospitalChonnam National University Hwasun HospitalHwasunRepublic of Korea
  3. 3.Department of Preventive Medicine & Institute of Wonkwang Medical ScienceWonkwang University School of MedicineIksanRepublic of Korea
  4. 4.Department of Preventive MedicineChungnam National University Medical SchoolDaejeonRepublic of Korea
  5. 5.Department of Preventive MedicineSeonam University College of MedicineNamwonRepublic of Korea
  6. 6.Genome Research Center for Hematopoietic DiseasesChonnam National University Hwasun HospitalHwasunRepublic of Korea
  7. 7.Department of NeurologyChonnam National University Medical SchoolGwangjuRepublic of Korea
  8. 8.Department of Neurology, Research Institute of Clinical Medicine Chonbuk National UniversityBiomedical Research Institute of Chonbuk National University HospitalJeonjuRepublic of Korea

Personalised recommendations